The Proceedings of the American Thoracic Society 2:26-33 (2005)
© 2005 The American Thoracic Society
Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Emiel F. M. Wouters
Department of Respiratory Medicine, University Hospital Maastricht, Maastricht, The Netherlands
Correspondence and requests for reprints should be addressed to Emiel F. M. Wouters, M.D., Ph.D., Department of Pulmonary Diseases, University Hospital Maastricht, P.O. Box 5800, 6202 As Maastricht, The Netherlands. E-mail: ewo{at}ms-azm-3.azm.nl
There is growing evidence for systemic inflammation in chronic obstructive pulmonary disease (COPD). Increased circulating levels of inflammatory cytokines and acute phase proteins occur in stable disease, and COPD exacerbations are notably associated with pulmonary and systemic inflammation. Although the course of inflammation is determined by the balance between pro- and antiinflammatory mediators, in COPD most attention has focused on the former. During exacerbation, however, upregulation of antiinflammatory markers occurs. The main causes of systemic inflammation in COPD remain to be elucidated, although systemic hypoxia is a candidate factor. Although a relationship between lung and systemic inflammation has been suggested, experimental evidence indicates no direct correlations in the regulation of inflammation in the pulmonary and systemic compartments. Longitudinal studies are needed to unravel the role of systemic inflammation in the course of COPD, to analyze the role of acute exacerbations on the chronicity of inflammation, and to evaluate the response of systemic inflammation to different interventions. Emphasis should be placed on the identification of signaling pathways induced and/or altered in skeletal muscle by inflammation, as muscle wasting is a prominent feature of chronic inflammatory disease conditions and contributes significantly to impaired physical functioning and health status in COPD.
Key Words: chronic obstructive pulmonary disease cytokines immune response systemic inflammation
This article has been cited by other articles:

|
 |

|
 |
 
L. Graat-Verboom, E. F. M. Wouters, F. W. J. M. Smeenk, B. E. E. M. van den Borne, R. Lunde, and M. A. Spruit
Current status of research on osteoporosis in COPD: a systematic review
Eur. Respir. J.,
July 1, 2009;
34(1):
209 - 218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Jolley and J. Moxham
A physiological model of patient-reported breathlessness during daily activities in COPD
Eur. Respir. Rev.,
June 1, 2009;
18(112):
66 - 79.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. M.T.A. van Durme, K. M.C. Verhamme, A.-J. L.H.J. Aarnoudse, G. R. Van Pottelberge, A. Hofman, J. C.M. Witteman, G. F. Joos, G. G. Brusselle, and B. H.C. Stricker
C-Reactive Protein Levels, Haplotypes, and the Risk of Incident Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
March 1, 2009;
179(5):
375 - 382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. MacNee, J. Maclay, and D. McAllister
Cardiovascular Injury and Repair in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
December 1, 2008;
5(8):
824 - 833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Falk, O. A. Minai, and Z. Mosenifar
Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2008;
5(4):
506 - 512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Brekke, T. Omland, S. H. Holmedal, P. Smith, and V. Soyseth
Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation
Eur. Respir. J.,
March 1, 2008;
31(3):
563 - 570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fuschillo, A. De Felice, and G. Balzano
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms
Eur. Respir. J.,
February 1, 2008;
31(2):
396 - 406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al.
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Eur. Respir. J.,
February 1, 2008;
31(2):
416 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Doucet, A. P. Russell, B. Leger, R. Debigare, D. R. Joanisse, M.-A. Caron, P. LeBlanc, and F. Maltais
Muscle Atrophy and Hypertrophy Signaling in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
August 1, 2007;
176(3):
261 - 269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ischaki, G. Papatheodorou, E. Gaki, I. Papa, N. Koulouris, and S. Loukides
Body Mass and Fat-Free Mass Indices in COPD: Relation With Variables Expressing Disease Severity
Chest,
July 1, 2007;
132(1):
164 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Sin and S. F. P. Man
Pharmacotherapy for Mortality Reduction in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
September 1, 2006;
3(7):
624 - 629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-C. L. Machado, J. A. Krishnan, S. A. Buist, A. L. Bilderback, G. P. Fazolo, M. G. Santarosa, F. Queiroga Jr., and W. M. Vollmer
Sex Differences in Survival of Oxygen-dependent Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
September 1, 2006;
174(5):
524 - 529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Update in chronic obstructive pulmonary disease 2005.
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1056 - 1065.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. I. Rennard
Chronic Obstructive Pulmonary Disease: Linking Outcomes and Pathobiology of Disease Modification
Proceedings of the ATS,
May 1, 2006;
3(3):
276 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Chapman, D. M. Mannino, J. B. Soriano, P. A. Vermeire, A. S. Buist, M. J. Thun, C. Connell, A. Jemal, T. A. Lee, M. Miravitlles, et al.
Epidemiology and costs of chronic obstructive pulmonary disease
Eur. Respir. J.,
January 1, 2006;
27(1):
188 - 207.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Thoracic Society.
|
|
|